Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Lyphe Dispensary Expands Noidecs V Range for Accessible Medical Cannabis

by
December 4, 2024
in Economy, Investing
0
Lyphe Dispensary Expands Noidecs V Range for Accessible Medical Cannabis
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Last Updated on:

Lyphe Dispensary has announced the extension of its Noidecs V collection, an affordable and premium-quality medical cannabis range developed in direct response to patient demand.

Building on the successful debut of Noidecs Vital Platinum OG in June 2024, the collection now features four additional products, offering patients a simplified selection process. The Noidecs VOne-VFour line, previously known as Vital, introduces four distinct options: VOne, VTwo, VThree, and VFour, each offering carefully calibrated THC levels.

VOne delivers the lowest THC content, ideal for those new to cannabis or seeking mild relief. THC levels increase progressively across the range, with VFour offering the highest concentration for experienced users, ensuring patients can easily match the product to their specific needs—all at an accessible price point.

“Patients are advocating for lower cost, yet sustainable options, and we want them to know that Lyphe is not only listening but taking action,” said Hayley Thompson, Managing Director at Lyphe Clinic. “The Noidecs VOne-VFour line aims to bridge the gap between quality and cost, offering patients a reliable and accessible option for managing their health conditions.”

Lyphe’s approach combines affordability with freshness and consistent quality, made possible by a streamlined supply chain and scaling efficiencies. The Noidecs V collection reflects the company’s dedication to addressing patient needs without compromising standards.

While VThree marks an exciting addition, regulatory changes by the MHRA will result in adjustments to the branding of “Vital,” though the underlying philosophy remains intact.

Noidecs VThree launches in Winter 2024, with the rest of the collection arriving in early 2025. Updates on availability will be announced soon.

ShareTweetPin

Related Posts

Blackstone Minerals
Investing

Blackstone Minerals

July 25, 2025
Top 3 US Lithium Stocks of 2025
Investing

Top 3 US Lithium Stocks of 2025

July 25, 2025
White House Unveils 90 Point AI Strategy
Investing

White House Unveils 90 Point AI Strategy

July 24, 2025
Walker Lane Resources Ltd. Announces Closing of Private Placement
Investing

Walker Lane Resources Ltd. Announces Closing of Private Placement

July 24, 2025
10 Biggest Cannabis Stocks in the US and Canada
Investing

10 Biggest Cannabis Stocks in the US and Canada

July 23, 2025
10 Biggest Cannabis Stocks in the US and Canada
Investing

10 Biggest Cannabis Stocks in the US and Canada

July 23, 2025
Next Post
Localis report suggests using the South East’s potential to drive national renewal and avoid crisis.

Localis report suggests using the South East’s potential to drive national renewal and avoid crisis.

Recommended

PHL growth to pick up modestly as inflation risks linger, IMF says

PHL growth to pick up modestly as inflation risks linger, IMF says

December 20, 2024
Delays in landing imports also affecting shipments of meat

Delays in landing imports also affecting shipments of meat

September 22, 2024
The Future of Hiring: Optimizing Job Interviews in a Digital Age

The Future of Hiring: Optimizing Job Interviews in a Digital Age

December 24, 2024
TDF yields slip on BSP, Fed bets

TDF yields slip on BSP, Fed bets

November 27, 2024
Survey Unveils UK Workers’ Desk-Break Habits Amid Mental Health Worries

Survey Unveils UK Workers’ Desk-Break Habits Amid Mental Health Worries

December 19, 2024
GBonds seen to boost retail investor participation

GBonds seen to boost retail investor participation

November 18, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved